Duchenne muscular dystrophy is characterised by progressive muscle weakness and variable brain involvement. In this review the authors describe the molecular underpinning of this brain involvement, and how genetic therapies improve behavioural outcomes in the dystrophic mouse models.
- Cyrille Vaillend
- Yoshitsugu Aoki
- Francesco Muntoni